SCHEMBL738593

SCHEMBL738593

C#Cc1c2ccccc2cc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
HSD17B10 Q99714 4/20 0.44
CYP1B1 Q16678 2/20 0.44
HIF1A Q16665 1/20 0.44
HTR2A P28223 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CYP1A2 P05177 5/20 0.41
HPGD P15428 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
GLA P06280 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP3A4 P08684 1/20 0.40
ERBB2 P04626 1/20 0.40
FYN P06241 1/20 0.40
MAOA P21397 1/20 0.40
ACHE P22303 1/20 0.40
AHR P35869 1/20 0.40
CYP19A1 P11511 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28903867 0.98 ALDH1A1 (0.45) ALDH1A1HSD17B10CYP1B1HIF1AHTR2A
SCHEMBL2834902 0.82 ALDH1A1 (0.40) ALDH1A1HSD17B10CYP1B1HIF1ACYP1A2
SCHEMBL29870054 0.81 CYP19A1 (0.46) ALDH1A1HSD17B10CYP1A2KDM4EMEN1
SCHEMBL1478052 0.81 CYP19A1 (0.46) ALDH1A1HSD17B10CYP1A2KDM4EMEN1
SCHEMBL14165957 0.79 ALDH1A1 (0.48) ALDH1A1HSD17B10CYP1B1HIF1AHTR2A
SCHEMBL9929156 0.79 CYP19A1 (0.42) ALDH1A1HSD17B10CYP1B1HIF1AKDM4E
SCHEMBL31323030 0.79 HPRT1 (0.37) ALDH1A1HSD17B10CYP1B1HIF1AHTR2A
SCHEMBL28460856 0.79 ALDH1A1 (0.32) ALDH1A1HSD17B10CYP1B1HIF1AHTR2A
SCHEMBL186912 0.78 CES1 (0.42) ALDH1A1HSD17B10CYP1B1HIF1AL3MBTL1
SCHEMBL29663912 0.78 CES1 (0.42) ALDH1A1HSD17B10CYP1B1HIF1AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3262055-B1 WATER SOLUBLE FLUORESCENT OR COLORED DYES COMPRISING CONJUGATING GROUPS SONY GROUP CORP (JP) 2026-04-22 EP claimed
EP-4137818-B1 USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS SONY GROUP CORP (JP) 2025-12-10 EP claimed
EP-3440136-B1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS SONY GROUP CORP (JP) 2025-07-23 EP claimed
CN-120152742-A Polymer with dual therapeutic agents 索尼集团公司 2025-06-13 CN claimed
CN-119997980-A Polymers with steroids or vitamins 索尼集团公司 2025-05-13 CN claimed
US-20250009898-A1 PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT SONY GROUP CORP (JP) 2025-01-09 US claimed
US-20240210408-A1 USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS SONY GROUP CORP (JP) 2024-06-27 US claimed
CN-118159296-A Automatic synthesis of polymeric double drugs 索尼集团公司 2024-06-07 CN claimed
CN-118043082-A Pyrrolobenzodiazepine conjugates for the treatment of cancer 索尼集团公司 2024-05-14 CN claimed
US-20240132725-A1 SPACING LINKER GROUP DESIGN FOR BRIGHTNESS ENHANCEMENT IN DIMERIC OR POLYMERIC DYES Sony Group Corporation (JP) 2024-04-25 US claimed
WO-2017173355-A1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES SONY CORPORATION (JP) 2017-10-05 WO claimed
WO-2017173348-A1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH RIGID SPACING GROUPS SONY CORPORATION (JP) 2017-10-05 WO claimed
WO-2016183185-A1 ULTRA BRIGHT DIMERIC OR POLYMERIC DYES SONY CORPORATION (JP) 2016-11-17 WO claimed
WO-2016138461-A1 WATER SOLUBLE FLUORESCENT OR COLORED DYES COMPRISING CONJUGATING GROUPS SONY CORPORATION (JP) 2016-09-01 WO claimed
EP-3019559-A1 WATER SOLUBLE FLUORESCENT OR COLORED DYES AND METHODS FOR THEIR USE Sony Corporation (JP) 2016-05-18 EP claimed
CN-105377994-A Water-soluble fluorescent or colored dyes and methods of use thereof SONY CORP 2016-03-02 CN claimed
WO-2015027176-A1 WATER SOLUBLE FLUORESCENT OR COLORED DYES AND METHODS FOR THEIR USE SONY CORPORATION (JP) 2015-02-26 WO claimed
US-20060234084-A1 OLED device with improved luminescent layer EASTMAN KODAK COMPANY 2006-10-19 US claimed
EP-0808855-B1 Fluorescent polymers and coating compositions ROHM & HAAS (US) 2002-07-17 EP claimed
EP-0365495-B1 9-Anthrylalkyl compounds, their preparation and their use EKA NOBEL AB (SE) 1994-03-16 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250009898-A1 PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT CHRM1, TPD52L2, H1-3 ALDH1A1 1901/4885HSD17B10 4468/4885CYP1B1 632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.